The Scientist

» clinical trials, disease/medicine and ecology

Most Recent

image: Stem Cells Not Rejected

Stem Cells Not Rejected

By | January 25, 2013

Researchers uncover more evidence that reprogrammed stem cells are not attacked by the immune system, suggesting they may one day serve as effective therapies.

1 Comment

image: Non-coding Mutations May Drive Cancer

Non-coding Mutations May Drive Cancer

By | January 24, 2013

The majority of human melanomas contain mutations in a gene promoter, suggesting mutations in regulatory regions may spur some cancers.

3 Comments

image: Bird Flu Research to Resume

Bird Flu Research to Resume

By | January 24, 2013

After a year-long voluntary moratorium to discuss regulations and safety measures, scientists are set to resume controversial H5N1 research.

1 Comment

image: Cancer Diet Shared by Healthy Cells

Cancer Diet Shared by Healthy Cells

By | January 23, 2013

Tumor cells rapidly divide by usurping a metabolic trick from normal cell development.

4 Comments

image: Some Insurers Protected by GINA

Some Insurers Protected by GINA

By | January 23, 2013

Long-term, life, and disability insurers may still be able to deny coverage to patients with a genetic disease, under current nondiscrimination legislation.

2 Comments

image: First Recombinant Flu Vaccine

First Recombinant Flu Vaccine

By | January 21, 2013

The US Food and Drug Administration approves the first flu vaccine made from recombinant proteins rather than a weakened virus.

1 Comment

image: Dung Defeats Drugs

Dung Defeats Drugs

By | January 18, 2013

Fecal transplants outcompeted traditional antibiotics at curing a deadly intestinal infection.

0 Comments

image: Spinning Clinical Trials

Spinning Clinical Trials

By | January 16, 2013

Results of breast cancer drug trials are regularly spun to conceal bias and make the drugs seem more effective or less toxic than they really are.

0 Comments

image: Bespoke Stem Cells for Brain Disease

Bespoke Stem Cells for Brain Disease

By | January 15, 2013

Scientists use virus-free gene therapy on patient-derived stem cells to repair spinal muscular atrophy in mice.

0 Comments

image: Researchers Risk Insider Trading

Researchers Risk Insider Trading

By | January 14, 2013

Academics get paid handsome fees to consult with the financial industry, but run the risk of revealing confidential information that leads to illicit gains.

0 Comments

Popular Now

  1. Gut Microbes Linked to Neurodegenerative Disease
  2. Opinion: WHO’s Silence on Cannabis
  3. Top 10 Innovations 2016
    Features Top 10 Innovations 2016

    This year’s list of winners celebrates both large leaps and small (but important) steps in life science technology.

  4. Infant Microbiome: Vaginal Delivery Versus C-Section
Rockland